Back to News
Market Impact: 0.15

Earnings Growth & Price Strength Make CBRE Group (CBRE) a Stock to Watch

CBRE
Corporate EarningsAnalyst EstimatesCompany FundamentalsAnalyst InsightsHousing & Real EstateCorporate Guidance & Outlook

Zacks' Focus List, an investment portfolio leveraging earnings estimate revisions, has demonstrated significant outperformance, generating a cumulative return of 2,519.23% from February 1996 to March 2021, compared to the S&P 500's 854.95%. Commercial real estate firm CBRE Group (CBRE) serves as a prime example of this strategy's efficacy, with its shares appreciating 328.65% to $156.03 since its addition to the list in March 2017 at $36.40. Recent analyst sentiment reinforces CBRE's positive trajectory, evidenced by three upward revisions to fiscal 2025 earnings estimates, raising the Zacks Consensus Estimate to $6.03, alongside a forecasted 18.2% earnings growth for the current fiscal year.

Analysis

CBRE Group (CBRE) is presented as a case study for a strategy focused on positive earnings estimate revisions. The commercial real estate firm has demonstrated significant long-term performance, with its share price appreciating 328.65% to $156.03 since its addition to the Zacks Focus List in March 2017. Current forward-looking indicators appear constructive, with forecasted earnings growth of 18.2% for the current fiscal year and a history of delivering an average positive earnings surprise of 9.4%. Furthermore, analyst sentiment for fiscal 2025 is trending positively, evidenced by three upward earnings estimate revisions in the last 60 days, which has lifted the consensus estimate to $6.03. However, it is notable that despite these positive fundamental signals and its historical performance, the stock currently holds a Zacks Rank of #3 (Hold), indicating a more neutral near-term outlook from the rating system compared to the #1 (Strong Buy) or #2 (Buy) ranks typically required for new additions to the Focus List.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo